LLS COVID-19 Patient Financial Aid Program

This fund is fully subscribed and closed to enrollment.

The Leukemia & Lymphoma Society (LLS) is grateful for the generous support of our industry partners who helped fund the LLS COVID-19 Patient Financial Aid Program, launched April 1.

While our fund is now fully depleted, patients' needs persist during this pandemic crisis. These financial hardships are on top of the challenges in managing their diagnosis and treatment, and LLS remains committed to doing everything possible to provide support to patients, families and caregivers, who can contact our Information Specialists at 800-955-4572. Patients and caregivers should also visit www.LLS.org/Finances to learn of other funding programs.


Thanks to our corporate partners

We thank the following partners for their longstanding commitment to our mission and for providing the generous funding needed to support patients through the LLS COVID-19 Patient Financial Aid Program:

Abbvie
Amgen
AstraZeneca
BMS
Burlington
Foundation Medicine
Genentech / Biogen
GSK
Incyte
Morphosys Foundation
The Pfizer Foundation
PHL COVID-19 Fund
Seattle Genetics
Servier
Subaru
Takeda Oncology
Walgreens
WaWa

Contact Us for One-on-One Support